This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Anticipated Shortage

APO-DAPAGLIFLOZIN-METFORMIN

APOTEX INC

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-DAPAGLIFLOZIN-METFORMIN in Canada?

Yes. APO-DAPAGLIFLOZIN-METFORMIN 5MG 850MG has an active shortage reported to Health Canada (last updated July 23, 2026).

Why is APO-DAPAGLIFLOZIN-METFORMIN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-DAPAGLIFLOZIN-METFORMIN be available again?

The manufacturer's estimated resolution date is December 4, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusAnticipated Shortage

Same-ingredient products on fileNone found

Affected strength5MG 850MG

Last updated2026-04-20

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

DIN

02536153

Strength

5MG 850MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

DAPAGLIFLOZIN METFORMIN HYDROCHLORIDE

Tier

Unrated

Last Updated

2026-04-20

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

APO-DAPAGLIFLOZIN-METFORMIN has 2 shortage/discontinuation reports on file — this is one of them.

2026-07-23

Active Shortage

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244